Hosted on MSN

Citi raises its price target on Merck & Co. (MRK) to $125 from $120

Merck & Co., Inc. (NYSE:MRK) is one of the 10 Most Profitable S&P 500 Stocks to Buy Now. On March 20, 2026, Citi raised the price target on Merck & Co., Inc. (NYSE:MRK) to $125 from $120 and ...
Insider Monkey

Merck & Co. (MRK) to Acquire Terns Pharma for $6.7 Billion

Merck & Co., Inc. (NYSE:MRK) is included in our list of the best stocks to buy for financial stability. On March 25, 2026, Merck & Co., Inc. (NYSE:MRK) came into the limelight when Reuters reported ...
CNBC

Final Trade: SPY, BTI, MRK, HAL

The final trades of the day with the 'Fast Money' traders. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this ...
Seeking Alpha

Terns Pharma shares surge on $6.7B Merck buyout deal at $53 per share

Merck (MRK), operating as MSD outside the U.S. and Canada, on Wednesday said it will acquire clinical-stage biotech Terns Pharmaceuticals (TERN) in an all-cash deal valued at approximately $6.7 ...
Seeking Alpha

Terns Pharma shares surge on reported $6B acquisition talks with Merck

Merck & Co. (MRK) is close to an approximately $6 billion all-cash deal to buy U.S. biotech firm Terns Pharmaceuticals (TERN) as it seeks to boost its drug pipeline ahead of cancer treatment ...
Reuters

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports

March 24 (Reuters) - Pharmaceutical company Merck (MRK.N), opens new tab is nearing a roughly $6 billion ‌all-cash deal to acquire biotech firm Terns Pharma (TERN.O), opens new tab, the Financial ...
The Business Journals

Greater Kansas City Chamber of Commerce unveils 2026 Top 10 Small Businesses

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min This year's Top 10 Small ...
Hosted on MSN

Merck (MRK) shares up significantly since Jim Cramer advised to "stay the course"

Merck & Co., Inc. (NYSE:MRK) is one of Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks. Merck & Co., Inc. (NYSE:MRK) aims to make an entry into the weight loss drug market through the HS-10535 ...
CNBC

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline

Merck will acquire Terns for $53 per share in cash, amounting to an equity value of about $6.7 billion. This is the third multibillion-dollar acquisition for Merck over the past year as it looks to ...